Mirae Asset Global Investments’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-17,051
Closed -$653K 2580
2024
Q1
$653K Sell
17,051
-2,502
-13% -$97.6K ﹤0.01% 1776
2023
Q4
$749K Buy
19,553
+453
+2% +$15.1K ﹤0.01% 1765
2023
Q3
$589K Buy
19,100
+2,049
+12% +$70.7K ﹤0.01% 1798
2023
Q2
$539K Hold
17,051
﹤0.01% 1914
2023
Q1
$622K Buy
17,051
+500
+3% +$17.5K ﹤0.01% 1820
2022
Q4
$490K Hold
16,551
﹤0.01% 1904
2022
Q3
$645K Buy
16,551
+5,286
+47% +$242K ﹤0.01% 1726
2022
Q2
$435K Buy
+11,265
New +$428K ﹤0.01% 1818

Other funds holding ASTH

Mirae Asset Global Investments's ASTH Position: Q2 2024 in Review

Mirae Asset Global Investments sold out of Astrana Health (ASTH) in Q2 2024, closing a stake of 17,051 shares — an estimated $653K sold.

Mirae Asset Global Investments first reported a position in ASTH in Q2 2022 and held it in 8 quarters. The position peaked at $749K in Q4 2023. 172 funds tracked by Wall St. Rank hold ASTH as of Q2 2024.

  • Mirae Asset Global Investments reported no remaining Astrana Health position as of Q2 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 17,051 Astrana Health shares in Q2 2024, an estimated $653K.
  • Mirae Asset Global Investments first reported a position in Astrana Health in Q2 2022 and held it in 8 quarters.
  • Mirae Asset Global Investments's Astrana Health position peaked at $749K in Q4 2023.
  • 172 funds tracked by Wall St. Rank held Astrana Health as of Q2 2024.

Based on Mirae Asset Global Investments's 13F filing for Q2 2024, filed 30 Jul 2024.